2. Search Result
Search Result
Results for "

DSPE-PEG3400

" in MedChemExpress (MCE) Product Catalog:

42

Inhibitors & Agonists

38

Biochemical Assay Reagents

4

Peptides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-143209B
    DSPE-PEG3400

    		Liposome Others
    DSPE-PEG3400 is a phospholipids-polymer conjugate that can be used in drug delivery applications. DSPE-PEG3400 is a material for the formulation of nanocarriers for achieving prolonged blood circulation time, improved stability and enhanced encapsulation efficiency .
    DSPE-PEG3400
  • HY-172278C
    DSPE-PEG3400-CGKRK

    		Liposome Cancer
    DSPE-PEG3400-CGKRK is a PEG compound which composed of DSPE and a cell-penetrating peptide (CGKRK). DSPE-PEG3400-CGKRK can be used for drug delivery .
    DSPE-PEG3400-CGKRK
  • HY-172681A
    DSPE-PEG3400-VIP

    		Liposome Inflammation/Immunology
    DSPE-PEG3400-VIP is a PEG compound which composed of DSPE and a vasoactive intestinal peptide (VIP). DSPE-PEG3400-VIP can be used for drug delivery .
    DSPE-PEG3400-VIP
  • HY-172279C
    DSPE-PEG3400-TAT

    		Liposome Infection
    DSPE-PEG3400-TAT is a PEG compound which composed of DSPE and a cell-penetrating peptide (TAT) (HY-P0281). DSPE-PEG3400-TAT can be used for drug delivery .
    DSPE-PEG3400-TAT
  • HY-172482A
    DSPE-PEG3400-TAASGVRSMH

    		Liposome Cancer
    DSPE-PEG3400-TAASGVRSMH is a PEG compound which composed of DSPE and TAASGVRSMH. TAASGVRSMH has a strong affinity for the NG2 proteoglycan on the PC membrane. DSPE-PEG3400-TAASGVRSMH can be used for drug delivery .
    DSPE-PEG3400-TAASGVRSMH
  • HY-172687A
    DSPE-PEG3400-CSTSMLKAC

    		Liposome Cardiovascular Disease
    DSPE-PEG3400-CSTSMLKAC is a PEG compound which composed of DSPE and a peptide (CSTSMLKAC). CSTSMLKAC is capable of mediating selective homing of phage to ischemic heart tissue. DSPE-PEG3400-CSTSMLKAC can be used for drug delivery .
    DSPE-PEG3400-CSTSMLKAC
  • HY-172684A
    DSPE-PEG3400-GRGDS

    		Liposome Others
    DSPE-PEG3400-GRGDS is a PEG compound which composed of DSPE and an anti-adhesion peptide (GRGDS). GRGDS can block the binding and adhesion of extracellular matrix to cell surface integrins. DSPE-PEG3400-GRGDS can be used for drug delivery .
    DSPE-PEG3400-GRGDS
  • HY-172696A
    DSPE-PEG3400-WYRGRL

    		Liposome Inflammation/Immunology
    DSPE-PEG3400-WYRGRL is a PEG compound which composed of DSPE and a cartilage-targeting peptide (WYRGRL). WYRGRL is a collagen II-targeting peptide that can bind to collagen II α1. DSPE-PEG3400-WYRGRL can be used for drug delivery .
    DSPE-PEG3400-WYRGRL
  • HY-172485A
    DSPE-PEG3400-LTLRWVGLMS

    		Liposome Cancer
    DSPE-PEG3400-LTLRWVGLMS is a PEG compound which composed of DSPE and a decapeptide (LTLRWVGLMS). The chondroitin sulfate proteoglygan NG2 is a receptor for LTLRWVGLMS. LLRWVGLMS shows the homing of pericytes associated with tumor blood vessels. DSPE-PEG3400-LTLRWVGLMS can be used for drug delivery .
    DSPE-PEG3400-LTLRWVGLMS
  • HY-172726A
    DSPE-PEG3400-EB1

    		Liposome Cancer
    DSPE-PEG3400-EB1 is a PEG compound which composed of DSPE and pH responsive membrane-penetrating peptide (EB1). DSPE-PEG3400-EB1 can be used for drug delivery .
    DSPE-PEG3400-EB1
  • HY-172277C
    DSPE-PEG3400-R9

    		Liposome Neurological Disease
    DSPE-PEG3400-R9 is a PEG compound which composed of DSPE and a poly-arginine-9 peptide (R9). DSPE-PEG3400-R9 can be used for drug delivery .
    DSPE-PEG3400-R9
  • HY-172699A
    DSPE-PEG3400-ANG

    		Liposome Cancer
    DSPE-PEG3400-ANG is a PEG compound which composed of DSPE and a dual-targeting ligand (Angiopep-2, ANG). ANG exhibits high LRP1 binding efficiency and has been used for glioma-targeting delivery. DSPE-PEG3400-ANG can be used for drug delivery .
    DSPE-PEG3400-ANG
  • HY-172280C
    DSPE-PEG3400-octreotide

    		Liposome Cancer
    DSPE-PEG3400-Octreotide is a PEG compound which composed of DSPE and a Octreotide (HY-P0036). Octreotide is a somatostatin receptor agonist. Octreotide has antitumor activity, mediates apoptosis and may also be used in disease studies in acromegaly. DSPE-PEG3400-Octreotide can be used for drug delivery .
    DSPE-PEG3400-octreotide
  • HY-172708A
    DSPE-PEG3400-PP1

    		Liposome Neurological Disease
    DSPE-PEG3400-PP1 is a PEG compound which composed of DSPE and a PP1 peptide. PP1 peptide targets the inflammatory atherosclerotic plaque. DSPE-PEG3400-PP1 can be used for drug delivery .
    DSPE-PEG3400-PP1
  • HY-172464A
    DSPE-PEG3400-cRGD

    		Liposome Integrin Cancer
    DSPE-PEG3400-cRGD is a PEG compound which composed of DSPE and an αvβ3 targeting peptide (cRGD). cRGD peptide can specifically bind to αvβ3 on the surface of many cancer cells and neovascular cells. DSPE-PEG3400-cRGD can be used for drug delivery .
    DSPE-PEG3400-cRGD
  • HY-172702A
    DSPE-PEG3400-NYZL1

    		Liposome Cancer
    DSPE-PEG3400-NYZL1 is a PEG compound which composed of DSPE and a NYZL1 peptide. NYZL1 can specifically bind to bladder cancer tissues and cells. DSPE-PEG3400-NYZL1 can be used for drug delivery .
    DSPE-PEG3400-NYZL1
  • HY-172470A
    DSPE-PEG3400-GE11

    		Liposome EGFR Cancer
    DSPE-PEG3400-GE11 is a PEG compound which composed of DSPE and an EGFR targeting peptide (GE11). GE11 can be used for EGFR overexpressed cancer cells. DSPE-PEG3400-GE11 can be used for drug delivery .
    DSPE-PEG3400-GE11
  • HY-172476A
    DSPE-PEG3400-YIGSR

    		Liposome Cancer
    DSPE-PEG3400-YIGSR is a PEG compound which composed of DSPE and a biomimetic peptide YIGSR. YIGSR interacts with the 67 kDa laminin binding protein (LBP) and promotes adhesion and spreading of a large number of cell types including endothelial cells, fibroblasts and smooth muscle cells. DSPE-PEG3400-YIGSR can be used for drug delivery .
    DSPE-PEG3400-YIGSR
  • HY-172723A
    DSPE-PEG3400-T7

    		Liposome Cancer
    DSPE-PEG3400-T7 is a PEG compound which composed of DSPE and a transferrin receptor (TfR) peptide (T7). T7 (HAIYPRH) specifically binds to TfR (transferrin receptor). DSPE-PEG3400-T7 can be used for drug delivery .
    DSPE-PEG3400-T7
  • HY-172494A
    DSPE-PEG3400-iRGD

    		Liposome Integrin Cancer
    DSPE-PEG3400-iRGD is a PEG compound which composed of DSPE and an αv-integrins targeting peptide (iRGD). iRGD peptide binds to αv-integrins, and then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1, and has tumor-targeting and tumor-penetrating properties. DSPE-PEG3400-iRGD can be used for drug delivery .
    DSPE-PEG3400-iRGD
  • HY-172503A
    DSPE-PEG3400-Mal-Cys-KAAKNK

    		Liposome Cancer
    DSPE-PEG3400-KAA is a PEG compound which composed of DSPE and a CKAAKNK peptide (KAA). KAA specifically binds to tumor vessels in RIP-Tag2 transgenic mice. DSPE-PEG3400-KAA can be used for drug delivery .
    DSPE-PEG3400-Mal-Cys-KAAKNK
  • HY-172497A
    DSPE-PEG3400-Mal-Cys-REKA

    		Liposome Cancer
    DSPE-PEG3400-CREKA is a PEG compound which composed of DSPE and a fibrin-targeting peptide (CREKA). CREKA peptide can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity. DSPE-PEG3400-CREKA can be used for drug delivery .
    DSPE-PEG3400-Mal-Cys-REKA
  • HY-172479A
    DSPE-PEG3400-F3

    		Liposome Cancer
    DSPE-PEG3400-F3 is a PEG compound which composed of DSPE and a nucleolin targeting peptide (F3). F3 peptide can specifically bind to cell surface nucleolin and undergo an effective cell surface to nucleus transport. DSPE-PEG3400-F3 can be used for drug delivery .
    DSPE-PEG3400-F3
  • HY-172488A
    DSPE-PEG3400-K237

    		Liposome Cancer
    DSPE-PEG3400-K237 is a PEG compound which composed of DSPE and a KDR targeting peptide (K237). K237 can functionally disrupt the interaction between VEGF and the KDR receptor and cause potent biological effects that include the inhibition of angiogenesis and tumor growth. DSPE-PEG3400-K237 can be used for drug delivery .
    DSPE-PEG3400-K237
  • HY-172690A
    DSPE-PEG3400-THRPPMWSPVWP

    		Liposome Cancer
    DSPE-PEG3400-THRPPMWSPVWP is a PEG compound which composed of DSPE and a transferrin receptor (TfR) peptide (THRPPMWSPVWP). THRPPMWSPVWP binds to the TfR and is subsequently internalized into TfR-expressing cells .
    DSPE-PEG3400-THRPPMWSPVWP
  • HY-172273C
    DSPE-PEG3400-Mal-Cys-YEQDPWGVKWWY

    		Liposome Cancer
    DSPE-PEG3400-M2pep is a PEG compound which composed of DSPE and a M2-polarized macrophages targeting peptide (M2pep). M2pep is conjugated to a proapoptotic peptide as monovalent or multivalent ligands to concentrate the toxic effect of the peptide to M2 macrophages. DSPE-PEG3400-M2pep can be used for drug delivery .
    DSPE-PEG3400-Mal-Cys-YEQDPWGVKWWY
  • HY-172491A
    DSPE-PEG3400-ESBP

    		Liposome Cancer
    DSPE-PEG3400-ESBP is a PEG compound which composed of DSPE and a E-selectin-binding peptide (ESBP). As a tumor-targeting peptide, ESBP can specifically recognize and bind to receptors or markers on the surface of tumor cells .
    DSPE-PEG3400-ESBP
  • HY-172711A
    DSPE-PEG3400-R6H4

    		Liposome Cancer
    DSPE-PEG3400-R6H4 is a PEG compound which composed of DSPE and pH responsive membrane-penetrating peptide (R6H4). R6H4 can be used for pH responsive anticancer drug delivery purposes. DSPE-PEG3400-R6H4 can be used for drug delivery .
    DSPE-PEG3400-R6H4
  • HY-172473A
    DSPE-PEG3400-NGR

    		Liposome Cancer
    DSPE-PEG34000-NGR is a PEG compound which composed of DSPE and an Asn-Gly-Arg (NGR) peptide. NGR peptide can target tumor vascular antigen CD13. DSPE-PEG3400-NGR can be used for drug delivery .
    DSPE-PEG3400-NGR
  • HY-172275C
    DSPE-PEG3400-Cys-SRNLIDC (Disulfide bridge: Cys1-Cys8)

    		Liposome Inflammation/Immunology
    DSPE-PEG3400-pPB is a PEG compound which composed of DSPE and a cyclic oligopeptide (pPB). pPB has a strong binding affinity with PDGFRβ, which is overexpressed on activated hepatic stellate cells (HSC). DSPE-PEG3400-pPB can be used for drug delivery .
    DSPE-PEG3400-Cys-SRNLIDC (Disulfide bridge: Cys1-Cys8)
  • HY-172500A
    DSPE-PEG3400-Mal-Cys-SFSHHTPILPLC

    		Liposome Cancer
    DSPE-PEG3400-SP94 is a PEG compound which composed of DSPE and a cell-penetrating peptide (SP94). SP94 shows specific binding to hepatocellular carcinoma (HCC) cells .
    DSPE-PEG3400-Mal-Cys-SFSHHTPILPLC
  • HY-172276C
    DSPE-PEG3400-Mal-Cys-RRRRRRRR

    		Liposome Cancer
    DSPE-PEG3400-R8 is a PEG compound which composed of DSPE and a cell-penetrating peptide (R8). pDSPE-PEG3400-R8 can be used for drug delivery .
    DSPE-PEG3400-Mal-Cys-RRRRRRRR
  • HY-172705A
    DSPE-PEG3400-RVG29

    		Liposome nAChR Infection
    DSPE-PEG3400-RVG29 is a PEG compound which composed of DSPE and a Rabies virus glycoprotein 29 (RVG29). RVG29 can bind specifically to the nicotinic acetylcholine receptor (nAChR) at the blood-brain barrier (BBB) and cross over the BBB .
    DSPE-PEG3400-RVG29
  • HY-172283C
    DSPE-PEG3400-BR2

    		Liposome Cancer
    DSPE-PEG3400-BR2 is a PEG compound which composed of DSPE and a BR2. BR2 is a targeting peptide composed of 17 amino acids with the sequence RAGLQFPVGRLLRRLLR. It has the ability to assist cells to penetrate the membrane and can specifically target certain cells or tissues .
    DSPE-PEG3400-BR2
  • HY-172714A
    DSPE-PEG3400-MPG

    		Liposome Infection
    DSPE-PEG3400-MPG is a PEG compound which composed of DSPE and a peptide vector (MPG). MPG is derived from both the nuclear localisation sequence (NLS) of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41. MPG could deliver short oligonucleotides into cells efficiently and independently of the endosomal pathway .
    DSPE-PEG3400-MPG
  • HY-172272C
    DSPE-PEG3400-Mal-Cys-ATWLPPR

    		Liposome VEGFR Cancer
    DSPE-PEG3400-A7R is a PEG compound which composed of DSPE and a tumor vascular targeting peptide (A7R). A7R exhibits high affinity and specificity for VEGFR-2, which is overexpressed in various tumors .
    DSPE-PEG3400-Mal-Cys-ATWLPPR
  • HY-172271C
    DSPE-PEG3400-Mal-Cys-CGNKRTRGC (Disulfide bridge: Cys2-Cys10)

    		Liposome Cancer
    DSPE-PEG3400-LyP-1 is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 targets tumor-associated lymphatic vessels and macrophages .
    DSPE-PEG3400-Mal-Cys-CGNKRTRGC (Disulfide bridge: Cys2-Cys10)
  • HY-172270C
    DSPE-PEG3400-Mal-Cys-KTLLPTP

    		Liposome Cancer
    DSPE-PEG1000-PTP is synthesised by conjugating the amino group of plectin-1 peptide (PTP) with DSPE-PEG-NHS ester via amide bonds. DSPE-PEG1000-PTP can be used to construct drug delivery vectors .
    DSPE-PEG3400-Mal-Cys-KTLLPTP
  • HY-169089
    RP-182-PEG3-K(palmitic acid)

    		Drug Derivative Cancer
    RP-182-PEG3-K palmitic acid (Compound 1a) is a fatty acid derivative of the immunomodulatory peptide RP-182. RP-182-PEG3-K palmitic acid inhibits CD206 high M2-like macrophage (IC50 of 3.2 μM) and induces phagocytosis. RP-182-PEG3-K palmitic acid exhibits antitumor efficacy in mouse B16 melanoma allografts .
    RP-182-PEG3-K(palmitic acid)
  • HY-P5112A
    Azido-PEG3-DYKDDDDK TFA

    Azido-PEG3-FLAG TFA

    		 Biochemical Assay Reagents Others
    Azido-PEG3-DYKDDDDK (azide-PEG3-FLAG) TFA is a multifunctional fusion tag for the purification of recombinant proteins. Azido-PEG3-DYKDDDDK TFA is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups .
    Azido-PEG3-DYKDDDDK TFA
  • HY-P5112
    Azido-PEG3-DYKDDDDK

    Azido-PEG3-FLAG

    		 Biochemical Assay Reagents Others
    Azido-PEG3-DYKDDDDK (azide-PEG3-FLAG) is a multifunctional fusion tag for the purification of recombinant proteins. Azido-PEG3-DYKDDDDK is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups .
    Azido-PEG3-DYKDDDDK
  • HY-P10319
    RI-STAD-2

    		PKA Cardiovascular Disease Cancer
    RI-STAD-2 is a high-affinity interfering peptide that regulates the subunit RI of protein kinase A (PKA). RI-STAD-2 interferes with the binding of AKAPs and PKA-RI by simulating the interaction between AKAPs' α-helix domain and PKA-RI's dimerization/anchoration (D/D) domain, thereby affecting PKA activity and intracellular localization. RI-STAD-2 can be used to study the role of AKAPs interaction with PKA-RI in pathological processes such as cardiovascular disease and cancer .
    RI-STAD-2

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: